Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • _anli
    Junior Member
    • Aug 2018
    • 4

    #1

    Calculating robustness using RTG Tools

    Hi.

    I'm evaluating a new NGS prep kit and want to calculate the robustness of the method by comparing the variant call from a samples which have been prepped twice.

    I've taken the approach of using rtg vcfeval, and then my calculation has has just been to take the true-pos-call divided by tru-pos call + false-pos + false-neg from the summary.txt file.

    I've been looking at using the --squash-ploidy option as well, but I'm not sure about it since I am using germline human whole genome samples.

    I've also seen people just using the F-measure as the robustness score, but I'm not sure if I truly understand how that is applicable.

    Is there anything wrong with the approach here? Should I be using --squash-ploidy for these samples? And how should one interpret the F-measure here?

    Cheers!

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Yesterday, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
16 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
71 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...